Position in ZTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$34,879,397
+$3,864,642 QoQ
Shares Held
295,063
+19.7% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97.84859504580378.ToString("F0")%
Shared 0.ToString("F0")%
None 2.1514049541962224.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026VICTORY CAPITAL MANAGEMENT INC holds $398,774,467 across 27 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
731,609 | $96,382,169 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,838,437 | $55,373,722 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
60,541 | $35,899,602 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
295,063 | $34,879,397 | |
| 5 | VTRS |
Viatris Inc
|
2,394,145 | $32,344,898 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
502,406 | $25,969,366 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
506,521 | $24,388,985 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
625,304 | $20,678,803 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $34,879,397 | 295,063 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $31,014,755 | 246,501 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $27,433,390 | 187,489 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $244,892,338 | 1,570,326 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $27,013,796 | 164,068 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $54,112,148 | 332,119 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $66,207,639 | 338,866 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $54,101,668 | 312,077 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $61,035,739 | 360,710 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $75,404,024 | 382,044 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $67,442,129 | 387,643 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $62,184,169 | 361,095 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $58,178,103 | 349,544 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $56,494,438 | 385,496 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $186,345,810 | 1,256,631 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $238,494,280 | 1,387,482 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $261,622,231 | 1,387,254 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $396,143,660 | 1,623,340 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $318,579,468 | 1,640,978 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $261,108,996 | 1,401,100 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $219,736,725 | 1,395,331 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $240,363,263 | 1,452,346 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $229,534,221 | 1,388,004 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $197,654,162 | 1,442,310 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $115,891,696 | 984,720 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||